Biology subjects

Vijayakumar, V.

Publications and source records attributed to Vijayakumar, V..

8 recordsLinked to original sources

bioRxiv2025

Developing a Stepwise Induction Protocol for Cisplatin-Resistant Human Cervical Cancer Cells

Cisplatin, a platinum-based DNA crosslinking chemotherapeutic, remains the cornerstone of first-line chemoradiation therapy for advanced cervical cancer. However, the clinical efficacy of cisplatin is frequently compromised by the emergence of acquired resistance, which represents a principal cause of treatment failure and disease recurrence. Traditional protocols for generating resistant cervical cancer cell lines vary widely in dose-escalation schedules, passage criteria, timing, and endpoints, often requiring months to yield inconsistent results. To overcome these limitations, this study establishes a structured, stepwise protocol for developing cisplatin-resistant cervical cancer cell lines using HeLa (HPV18+) and SiHa (HPV16+) models. We hypothesised that a predefined dosing and monitoring scheme would shorten induction time while improving the reproducibility of resistance generation. Using this approach, we successfully generated cisplatinresistant sublines (H1CR and S1CR) that exhibited rightward shifts in cisplatin IC50 (1.28-fold in HeLa and 1.80-fold in SiHa) and stable resistant phenotypes after drug withdrawal and cryopreservation. The present work therefore focuses on methodological standardisation of cisplatin resistance induction rather than exhaustive molecular characterisation, providing a clear starting point for future mechanistic and translational studies.

cancer biology↗

bioRxiv2025

Plasmidome, resistome, and virulence-associated genes characterization of Acinetobacter johnsonii in NASA cleanrooms and a clinical setting.

Evidence shows persistence of non-spore-forming Acinetobacter johnsonii in high-stakes controlled and nutrient-limited environments. This study aims to explore the mechanisms underpinning such adaptability through a comprehensive genomic analysis of 22 isolates of A. johnsonii from NASAs Payload Hazardous Servicing Facility (PHSF) and one carbapenem-resistant strain (E154408A) from patient colonization in Ireland. Core-genome phylogeny revealed clustering of PHSF-originating isolates in a monophyletic clade divergent from the main species lineage. Species-wide virulence-associated genes and metabolic profiling indicated the unique presence in PHSF-originating isolates of two complete efflux pumps and of a conserved allantoin racemase, suggesting adaptability for multiple environmental stresses. Observed ubiquity of blaOXA in investigated genomes (n=112) and phenotypically-validated multidrug-resistant profile of E154408A strain highlight A. johnsoniis potential as antimicrobial resistance (AMR) reservoir. Plasmidome analysis suggested gain/loss events across the monophyletic population and potential AMR acquisition pathways. Genome-to-metagenome mapping identified genomic signatures of A. johnsonii in PHSF >10 years post initial isolation. ImportanceAcinetobacter johnsonii is increasingly recognized as an emerging human pathogen, with growing evidence of its ability to persist in controlled, high-stakes environments, posing risks as both persisting environmental contaminant and antimicrobial resistance (AMR) reservoir. Yet, gaps remain in our understanding of its AMR profile and the mechanisms that enable its enhanced environmental adaptability. This knowledge is necessary in contexts where biological cleanliness is a priority such as clinical settings and spacecraft assembly facilities cleanrooms, where contamination of hardware with terrestrial microorganisms is concerning. In this study, we aim to address some of key knowledge gaps by providing genomic insights into a rare multi-drug resistant clinical isolate and 22 NASA cleanroom isolates that persisted for over a decade in extremely clean conditions. Our findings will help evaluate the contamination risk of A. johnsonii in high-stakes environments and ultimately strengthen our ability to manage this microbial contaminant across terrestrial and extraterrestrial settings. HighlightsO_LICleanrooms-derived A. johnsonii genomes show favorable traits for increased adaptability C_LIO_LIGenomic signatures of A. johnsonii persisted in the cleanrooms for >10 years C_LIO_LIblaOXA is ubiquitously found in the genome of all A. johnsonii C_LIO_LIE154408A is the first patient colonization by carbapenem-resistant A. johnsonii in Europe C_LI

genomics↗

bioRxiv2025

Unveiling Hidden Microbial Diversity in Mars2020 Mission Assembly Cleanrooms withMolecular Insights into the Persistent andPerseverance of Novel Species DefyingMetagenome Sequencing

NASA cleanrooms, where space mission components are assembled, maintain stringent cleaning protocols and nutrient-poor environments, resulting in low yet persistent microbial loads. Although these oligotrophic extremophiles are reported in small numbers, their resistance to environmental stresses, sparse presence, and difficulty in extracting biomolecules often lead to their omission, even with advanced sequencing technologies. Traditional metagenomic approaches fail to detect these rare species due to challenges in lysing robust microbial cells and isolating minute amounts of DNA from dominant microorganisms. Additionally, the absence of database references for novel extremophiles limits their identification. Over a six month period of monitoring Mars 2020 mission cleanrooms, 182 bacterial strains from 19 families were identified using advanced molecular techniques. This included 14 novel Gram-positive species, eight of which were spore-formers. Despite being present at only about 0.001% abundance in metagenomic sequencing data, they were successfully cultured. Functional studies revealed their capabilities in nitrogen cycling, carbohydrate metabolism, and radiation resistance. Furthermore, 12 biosynthetic gene clusters, including those linked to ectoine and{varepsilon} -poly-L-lysine production, underscore their biotechnological potential. These findings emphasize the hidden microbial diversity in spacecraft assembly cleanrooms and highlight the need for advanced detection methods to uncover extremophiles with potential applications in biotechnology and space exploration. SynopsisUnderstanding extremophiles in NASA spacecraft assembly cleanrooms aids contaminant management in confined habitats, ensuring sustainability and safety in future space missions.

genomics↗

bioRxiv2024

D-Serine inhibits non-ionotropic NMDA receptor signaling

NMDA-type glutamate receptors (NMDARs) are widely recognized as master regulators of synaptic plasticity, most notably for driving long-term changes in synapse size and strength that support learning. NMDARs are unique among neurotransmitter receptors in that they require binding of both neurotransmitter (glutamate) and co-agonist (e.g. O_SCPLOWDC_SCPLOW-serine) to open the receptor channel, which leads to the influx of calcium ions that drive synaptic plasticity. Over the past decade, evidence has accumulated that NMDARs also support synaptic plasticity via ion flux-independent (non-ionotropic) signaling upon the binding of glutamate in the absence of co-agonist, although conflicting results have led to significant controversy. Here, we hypothesized that a major source of contradictory results can be attributed to variable occupancy of the co-agonist binding site under different experimental conditions. To test this hypothesis, we manipulated co-agonist availability in acute hippocampal slices from mice of both sexes. We found that enzymatic scavenging of endogenous co-agonists enhanced the magnitude of LTD induced by non-ionotropic NMDAR signaling in the presence of the NMDAR pore blocker, MK801. Conversely, a saturating concentration of O_SCPLOWDC_SCPLOW-serine completely inhibited both LTD and spine shrinkage induced by glutamate binding in the presence of MK801. Using a FRET-based assay in cultured neurons, we further found that O_SCPLOWDC_SCPLOW-serine completely blocked NMDA-induced conformational movements of the GluN1 cytoplasmic domains in the presence of MK801. Our results support a model in which O_SCPLOWDC_SCPLOW-serine inhibits ion flux-independent NMDAR signaling and plasticity, and thus O_SCPLOWDC_SCPLOW-serine availability could serve to modulate NMDAR signaling even when the NMDAR is blocked by magnesium. Significance StatementNMDARs are glutamate-gated cation channels that are key regulators of neurodevelopment and synaptic plasticity and unique in their requirement for binding of a co-agonist (e.g. O_SCPLOWDC_SCPLOW-serine) in order for the channel to open. NMDARs have been found to drive synaptic plasticity via non-ionotropic (ion flux-independent) signaling upon the binding of glutamate in the absence of co-agonist, though conflicting results have led to controversy. Here, we found that O_SCPLOWDC_SCPLOW-serine inhibits non-ionotropic NMDAR-mediated LTD and LTD-associated spine shrinkage. Thus, a major source of the contradictory findings might be attributed to experimental variability in O_SCPLOWDC_SCPLOW-serine availability. In addition, the developmental regulation of O_SCPLOWDC_SCPLOW-serine levels suggests a role for non-ionotropic NMDAR plasticity during critical periods of plasticity.

neuroscience↗

bioRxiv2022

Reclassification of probiotic Lactobacillus acidophilus NCIMB 30184 as Lactobacillus helveticus and Lactobacillus casei NCIMB 30185 as Lacticaseibacillus paracasei

The strains NCIMB 30184 and NCIMB 30185, originally designated as Lactobacillus acidophilus and Lactobacillus casei respectively, have been studied in published pre-clinical and clinical studies. Their nucleotide sequences of the 16S rRNA were compared with public databases and were preliminarily found to have the highest similarity with Lactobacillus helveticus and Lacticaseibacillus paracasei species respectively. Subsequently, total 16S and 23S rRNA genes were compared with their most similar taxa, and the preliminary identification as Lactobacillus helveticus and Lacticaseibacillus paracasei were confirmed.

microbiology↗

bioRxiv2021

SARS-CoV-2 Viral Replication in a High Throughput Human Primary Epithelial Airway Organ Model

COVID-19 emerged as a worldwide pandemic early in 2020, and at this writing has caused over 170 million cases and 3.7 million deaths worldwide, and almost 600,000 deaths in the United States. The rapid development of several safe and highly efficacious vaccines stands as one of the most extraordinary achievements in modern medicine, but the identification and administration of efficacious therapeutics to treat patients suffering from COVID-19 has been far less successful. A major factor limiting progress in the development of effective treatments has been a lack of suitable preclinical models for the disease, currently reliant upon various animal models and in vitro culture of immortalized cell lines. Here we report the first successful demonstration of SARS-CoV-2 infection and viral replication in a human primary cell-based organ-on-chip, leveraging a recently developed tissue culture platform known as PREDICT96. This successful demonstration of SARS-CoV-2 infection in human primary airway epithelial cells derived from a living donor represents a powerful new pathway for disease modeling and an avenue for screening therapeutic candidates in a high throughput platform.

bioengineering↗

bioRxiv2018

Fungal adaptation to plant defenses through convergent assembly of metabolic modules

The ongoing diversification of plant defense compounds exerts dynamic selection pressures on the microorganisms that colonize plant tissues. Evolutionary processes that generate resistance towards these compounds increase microbial fitness by giving access to plant resources and increasing pathogen virulence. These processes entail sequence-based mechanisms that result in adaptive gene functions, and combinatorial mechanisms that result in novel syntheses of existing gene functions. However, the priority and interactions among these processes in adaptive resistance remains poorly understood. Using a combination of molecular genetic and computational approaches, we investigated the contributions of sequence-based and combinatorial processes to the evolution of fungal metabolic gene clusters encoding stilbene cleavage oxygenases (SCOs), which catalyze the degradation of biphenolic plant defense compounds known as stilbenes into monophenolic molecules. We present phylogenetic evidence of convergent assembly among three distinct types of SCO gene clusters containing alternate combinations of phenolic catabolism. Multiple evolutionary transitions between different cluster types suggest recurrent selection for distinct gene assemblages. By comparison, we found that the substrate specificities of heterologously expressed SCO enzymes encoded in different clusters types were all limited to stilbenes and related molecules with a 4-OH group, and differed modestly in substrate range and activity under the experimental conditions. Together, this work suggests a primary role for genome structural rearrangement, and the importance of enzyme modularity, in promoting fungal metabolic adaptation to plant defense chemistry.

evolutionary biology↗

bioRxiv2017

Horizontal gene cluster transfer increased hallucinogenic mushroom diversity

Secondary metabolites are heterogeneous natural products that often mediate interactions between species. The tryptophan-derived secondary metabolite, psilocin, is a serotonin receptor agonist that induces altered states of consciousness. A phylogenetically disjunct group of mushroom-forming fungi in the Agaricales produce the psilocin prodrug, psilocybin. Spotty phylogenetic distributions of fungal compounds are sometimes explained by horizontal transfer of metabolic gene clusters among unrelated fungi with overlapping niches. We report the discovery of a psilocybin gene cluster in three hallucinogenic mushroom genomes, and evidence for its horizontal transfer between fungal lineages. Patterns of gene distribution and transmission suggest that psilocybin provides a fitness advantage in the dung and late wood-decay niches, which may be reservoirs of fungal indole-based metabolites that alter behavior of mycophagous and wood-eating invertebrates. These hallucinogenic mushroom genomes will serve as models in neurochemical ecology, advancing the prospecting and synthetic biology of novel neuropharmaceuticals.

evolutionary biology↗